[1]
Hiroshi Bando 2021. Current Perspectives for Oral Hypoglycemic Agents with Clinical Evidence of Larger Studies. Diabetes Research. 7, 1 (Jun. 2021), e1-e3. DOI:https://doi.org/10.17140/DROJ-7-e016.